Physio-Friendly Remission-Facilitating Pharmacotherapy (PRP) in Type 2 Diabetes Authors Sanjay Kalra Department of Endocrinology, Bharti Hospital, Karnal, India; University Center for Research & Development, Chandigarh University, Mohali, India; Suneet Verma Department of Medicine, Alchemist Hospital, Panchkula, India; Nitin Kapoor Department of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, India; Non-communicable disease unit, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia. DOI: https://doi.org/10.47391/JPMA.24-89 Abstract This brief communication describes the concept of physiofriendlypharmacotherapy for type 2 diabetes mellitus.Physio-friendly therapy is defined as that which restoresmetabolic, including glycaemic and weight homoeostasis,to near normal levels. Drugs such as glucagon likepeptide 1 receptor agonists (GLP1RA), sodium glucose cotransporter-2 inhibitors (SGLT2i), and alfa glucosidaseinhibitors, along with metformin, work in a physio-friendlymanner and may facilitate remission. Thus, they can also betermed as remission-facilitating drugs.Keywords: Diabetes, relapse, remission, person centredcare, type 2 diabetes Downloads Full Text Article Published 2024-10-16 How to Cite Sanjay Kalra, Suneet Verma, & Nitin Kapoor. (2024). Physio-Friendly Remission-Facilitating Pharmacotherapy (PRP) in Type 2 Diabetes. Journal of the Pakistan Medical Association, 74(11), 2012–2013. https://doi.org/10.47391/JPMA.24-89 More Citation Formats ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver Download Citation Endnote/Zotero/Mendeley (RIS) BibTeX Issue Vol. 74 No. 11 (2024): NOVEMBER Section RECENT ADVANCES IN ENDOCRINOLOGY License Copyright (c) 2024 Journal of the Pakistan Medical Association This work is licensed under a Creative Commons Attribution 4.0 International License.